Effects of histamine and 5-hydroxytryptamine on the growth rate of xenografted human bronchogenic carcinomas

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 465-471

  Sheehan, Peter F J ^a   Baker, Timothy ^a   Tutton, Peter J M ^a   Barkla, David H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

5 hydroxytryptamine; bronchogenic carcinoma; histamine; xenograft

Indexed keywords

4 METHYLHISTAMINE; 5 HYDROXYINDOLEACETIC ACID; CIMETIDINE; CINANSERIN; FENFLURAMINE; FLUOXETINE; HISTAMINE; KETANSERIN TARTRATE; METITEPINE; QUIPAZINE;

ARTICLE; CANCER GRAFT; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA;

EID: 0029885519     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02762.x     Document Type: Article

References (66)

1. Schienmann P, Lebel B, Lynch NR, Salomon JC, Paupe JR, Burtin C. Histamine levels in blood and other tissues of male and female C3H mice. III. Mice carrying a 3-methylcholanterene induced tumour. Agents Actions 1979; 9: 95-6.
2. Burtin C, Shienmann P, Salomon JC et al. Increased tissue histamine in tumour bearing mice and rats. Br. J. Cancer 1981; 43: 684-8.
3. Rosengren E, Henningson A, Henningson S, Persson L. Polyamine levels as related to growth and hormones. Med. Biol. 1981; 59: 320-6.
4. Kahlson G, Rosengren E. Biogenesis and Physiology of Histamine. Edward Arnold Ltd, London. 1971; 215-50.
5. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Goodman LS, Gillman A (eds). The Pharmacological Basis of Therapeutics. 7th edn. MacMillan, New York. 1985; 605-38.
6. Bartholeyns J, Fozard JR. Role of histamine in tumour development. Trends Pharm. Sci. 1985; 123-5.
7. Tutton PJM. Influence of histamine on epithelial crypt cell proliferation in the jejunum of the rat. Clin. Exp. Pharmacol. Physiol. 1976; 3: 369-73.
8. Tutton PJM, Barkla DH. Cell proliferation in dimethylhydrazine-induced colonie adenocarcinomas following cytotoxic drug treatment. Virchows Arch. Cell. Pathol. 1978; 28: 151-6.
9. 2 receptor antagonists. Anticancer Res. 1983; 3: 7-10.
10. Tutton PJM, Barkla DH. Biogenic amines as regulated of the proliferated activity of normal and neoplastic intestinal epithelial cells (review). Anticancer Res. 1987; 7: 1-12.
11. Kikuchi Y, Oomori K, Kato K. Effects of cimetidine on growth and immune function in nude mice bearing human ovarian carcinoma. J. Natl Cancer Inst. 1985; 74: 495-8.
12. Adams WJ, Lawson JA, Nicholson SE, Cook TA, Morris DL. The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur. J. Surg. Oncol. 1993; 19: 332-5.
13. Van der Yen LTM, Prinsen IM, Jansen GH et al. Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists. Br. J. Cancer 1993; 68: 475-83.
14. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994; 35: 1632-6.
15. ic receptor antagonists and a-fluoromethylhistidine on the growth of human colorectal cancer in the subrenal capsule assay. Agents Actions 1994; C118-20.
16. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet 1994; 344: 1768-9.
17. Nielsen HJ, Hammer HJ, Mosegaard F, Kehlet H. Possible role of histamine-2 receptor antagonists for adjuvant treatment in colorectal cancer. Eur. J. Surg. 1991; 8: 437-41.
18. MacDonald RA, Schmid R, Hakala TR, Mallory GK. Effects of serotonin upon liver cells of young rats. Proc. Soc. Exp. Biol. 1959; 101: 83-6.
19. Mann PR. Effects of various substances on DNA synthesis in guinea-pig skin in vitro. Nature 1967; 216: 715-16.
20. Norrby K. Effect of heparin, histamine and serotonin on the density dependent inhibition of replication in two fibroblastic cell lines. Virchows Arch. B Cell. Pathol. 1973; 15: 75-93.
21. Tutton PJM. The influence of serotonin on crypt cell proliferation in the jejunum of rat. Virchows Arch. B Cell. Pathol. 1974; 16: 79-87.
22. 1B receptors coupled to a G1-protein. Nature 1988; 335: 254-6.
23. Kavanaugh WM, Williams LT, Ives HE, Coghlin SR. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol. Endocrinol. 1988; 2: 599-605.
24. Seuwen K, Pouyssegur J. Serotonin as a growth factor. Biochem. Pharmacol. 1990; 39: 985-90.
25. Terzakis JA, Sommers S, Andersson B. Neurosecretory appearing cells of human segmental bronchi. Lab. Invest. 1972; 26: 127-32.
26. Gould VE, Linnoila RI, Memoli VA, Warren WH. Biology of disease neuroendocrine components of the bronchopulmonary tract: Hyperplasias, dysplasias, and neoplasms. Lab. Invest. 1983; 49: 519-37.
27. Gould VE, Moll R, Moll I, Lee I, Franke WW. Neuroendocrine (Merkel) cells of the skin: Hyperplasias, dysplasias, and neoplasms. Lab. Invest. 1985; 52: 334-53.
28. Lauweryns JM, Peuskens JC, Cockelarere M. Argyrophil, fluorescent and granulated (peptide and amine producing?) AFG cells in human infant bronchial epithelium: Light and electron microscopic studies. Life Sci. 1970; 9: 1417-29.
29. Stahlman MT, Gray ME. Ontogeny of neuroendocrine cells in human fetal lung. I. An electron microscopic study. Lab. Invest. 1984; 51: 449-63.
30. Linnoila RI, Becker KI, Silva OL, Snider RH, Moore CF. Calcitonin as a marker for diethylnitrosamine-induced pulmonary endocrine cells in hyperplasia in hamsters. Lab. Invest. 1984; 51: 39-45.
31. Gazdar AF, Carney DN, Russell EK et al. Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation properties. Cancer Res. 1980; 40: 3502-7.
32. Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res. 1990; 50: 6632-5.
33. Itai S, Nishikata J, Takahashi N et al. Differentiation-dependent expression of 1 and sialyl I antigens in the developing lung of human embryos and in lung cancers. Cancer Res. 1990; 50: 7603-11.
34. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K. Immunohistochemical evidence of autocrine growth factors in adrenocarcinoma of the human lung. Cancer Res. 1990; 50: 7077-80.
35. Tungekar MF, Turley H, Dunnill MS, Gatter KC, Ritter MA, Harris AL. Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res. 1991; 51: 261-4.
36. 2-receptors in human lung cancer. Biochem. Mol. Biol. Int. 1993; 31: 399-404.
37. Armitage JO, Sidner AD. Antitumour effects of cimetidine? Lancet 1979; i: 882-3.
38. Bartholyens J, Bouclier M. Involvement of histamine in growth of mouse and rat tumours: Antitumoral properties of monofluoromethylhistidine, an enzyme-activated inhibitor of histidine decarboxylase. Cancer Res. 1984; 44: 639-45.
39. Osband ME, Shen Y, Schlesinger M et al. Successful tumour immunotherapy with cimetidine in mice. Lancet 1981; i: 636-38.
40. Steel GG, Courtney VD, Rostom AY. Improved immunosuppression techniques for xenografting of human tumours. Br. J. Cancer 1978; 37: 224-30.
41. Tutton PJM, Barkla DH. Comparison of the effects of ornithine decarboxylase inhibitor on the intestinal epithelium and intestinal tumours. Cancer Res. 1986; 46: 6091-4.
42. Tutton PJM, Barkla DH. Amine dependence of proliferative activity in two transplantable lines of mouse colonie carcinoma. Virchows Arch. & Cell Pathol. 1987; 53: 161-5.
43. Tutton PJM, Barkla DH. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br. J. Cancer 1982; 46: 260-5.
44. Tutton PJM, Barkla DH. Serotonin receptors influencing cell proliferation in the jejunal epithelium and in colonie adenocarcinomas. Anticancer Res. 1986; 6: 1123-6.
45. Tutton PJM, Steel GG. Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br. J. Cancer 1979; 40: 743-9.
46. Barkla DH, Tutton PJM. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumours. J. Natl Cancer Inst. 1981; 67: 1207-12.
47. Bauer HCF, Brosjo O, Brostrom L, Nilsson OS, Reinholt FP, Tribukait B. Growth of ploidy of human osteosarcoma xenografts in serial passage in nude mice. Eur. J. Cancer Clin. Oncol. 1986; 22: 821-30.
48. Euhus DM, Hudd C, La Regina MC, Johnson FE. Tumour measurement in the nude mouse. J. Surg. Oncol. 1986; 31: 229-34.
49. Floershiem GL, Bieri A, Chiodetti N. Xenograts in pharmacologically immunosuppressed mice as a mode to test the chemotherapeutic sensitivity of human tumors. Int. J. Cancer 1986; 37: 109-14.
50. Elprana D, Kuijpers W, Van Den Broek P, Wagener DJT. Growth characteristics of head and neck squamous cell carcinoma in nude mice. Eur. J. Cancer Clin. Oncol. 1986; 22: 1211-22.
51. Cole SPC, Campling BG, Dexter DF, Holden JJA, Roder JC. Establishment of a human large cell lung tumour line (QU-DB) with metastatic properties in athymic mice. Cancer 1986; 58: 917-23.
52. Fergusson RJ, Carmichael J, Smyth JF. Human tumour xenografts growing in immunodeficient mice: A useful model for assessing chemotherapeutic agents in bronchial carcinoma. Thorax 1986; 41: 376-80.
53. Michelson S, Glicksman AS, Leith JT. Growth in solid heterogenous human colon adenocarcinomas: Comparison of simple logistical models. Cell Tissue Kinetics 1987; 20: 343-55.
54. 2 mediation of acute behavioural effects of hallucinogens in rats. Psychopharmacology 1990; 100: 417-25.
55. Zink MH, Pergola PE, Doane JF, Sved AF, Alper RH. Quipazine increases renin release by a peripheral hemodynamic mechanism. J. Cardiovasc. Pharmacol. 1990; 15: 1-9.
56. Catto-Smith AG, Patrick MK, Hardin JA, Gall DG. Intestinal anaphalaxis in the rat: Mediators responsible for the ion transport abnormalities. Agents Actions 1981; 28: 185-91.
57. Hoffmann P, Skarphedinson JO, Delle M, Thoren P. Electrical stimulation of the gastrocnemius muscle in the spontaneously hypertensive rat increases the pain threshold: A role of different serotonergic receptors. Acta Physiol. Scand. 1990; 138: 125-31.
58. Christensen AV, Fjalland B, Pederson V, Dannerskjold-Samsoe P, Svedsen O. Pharmacology of a new phthalene (Lu 10.171) with a specific 5HT uptake inhibiting properties. Eur. J. Pharmacol. 1977; 41: 153-62.
59. 1A receptors induces lower lip retraction in the rat. Pharmacol. Biochem. Behav. 1989; 33: 821-7.
60. Ganellin CR, Parsons ME. Pharmacology of histamine receptors. In: Goodman LS, Gilman A (eds). The Pharmacological Basis of Therapeutics, 9th edn. MacMillan, New York. 1996; 581-600.
61. 2-receptor antagonist ranitidine. Scand. J. Gastroenterol. 1981; 16: 39-41.
62. Sporn MB, Roberts AB. Automne growth factors and cancer. Nature 1985; 313: 745-7.
63. Steel GG, Courtney VD, Phelps TA, Peckham MJ. The therapeutic response of human tumour xenografts. In: Sparrow S (ed.). Immunodeficient Animals for Cancer Research. MacMillan Press, London. 1980; 179-89.
64. Jain RK. Determinants of tumour blood flow: A review. Cancer Res. 1988; 48: 2641-58.
65. Kallinowksi F, Schlenger KH, Runkel S, Kloes M, Okunieff P, Vaupel P. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumour xenografts. Cancer Res. 1989; 49: 3759-64.
66. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumour cells. Cancer Res. 1981; 41: 73-81.